Your browser doesn't support javascript.
loading
Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma.
Tomiyama, Nami; Tasaki, Yoshihiko; Hamamoto, Shuzo; Sugiyama, Yosuke; Naiki, Taku; Etani, Toshiki; Taguchi, Kazumi; Matsuyama, Nayuka; Sue, Yasuhito; Mimura, Yoshihisa; Odagiri, Kunihiro; Noda, Yusuke; Aoki, Maria; Moritoki, Yoshinobu; Nozaki, Satoshi; Kurokawa, Satoshi; Okada, Atsushi; Kawai, Noriyasu; Furukawa-Hibi, Yoko; Yasui, Takahiro.
Affiliation
  • Tomiyama N; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Tasaki Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Hamamoto S; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Sugiyama Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Naiki T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Etani T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Taguchi K; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Matsuyama N; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Sue Y; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Mimura Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Odagiri K; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Noda Y; Department of Urology, Toyota Kosei Hospital, Toyota, Aichi, Japan.
  • Aoki M; Department of Urology, Nagoya East Medical Center, Nagoya, Aichi, Japan.
  • Moritoki Y; Department of Urology, Anjo Kosei Hospital, Anjo, Aichi, Japan.
  • Nozaki S; Department of Urology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
  • Kurokawa S; Department of Urology, Nagoya Tokushukai General Hospital, Kasugai, Aichi, Japan.
  • Okada A; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Kawai N; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Furukawa-Hibi Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Yasui T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Int J Urol ; 30(9): 754-761, 2023 09.
Article in En | MEDLINE | ID: mdl-37150513
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Urol Journal subject: UROLOGIA Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Urol Journal subject: UROLOGIA Year: 2023 Type: Article Affiliation country: Japan